AGTR1 and COVID-19: We found significantly increased AT1R (14.0; IQR, 12.5–19.5) in COVID-19 patients compared to IMV controls (6.0; IQR, 4.0–12.5) (p=0.002) and significantly increased ETAR (13.0; IQR, 10.5–15.0) compared to IMV controls (7.0; IQR, 4.0–10.0) (Figures 3A, B, p<0.001).